Metabolic alterations mediated by STAT3 promotes drug persistence in CML
Open accessThe DOI matches its Crossref record; 75 of the 77 references it cites were found in a registry or an index.
Abstract
Leukemic stem cells (LSCs) can acquire non-mutational resistance following drug treatment leading to therapeutic failure and relapse. However, oncogene-independent mechanisms of drug persistence in LSCs are incompletely understood, which is the primary focus of this study. We integrated proteomics, transcriptomics, and metabolomics to determine the contribution of STAT3 in promoting metabolic changes in tyrosine kinase inhibitor (TKI) persistent chronic myeloid leukemia (CML) cells. Proteomic and transcriptional differences in TKI persistent CML cells revealed BCR-ABL-independent STAT3 activation in these cells. While knockout of STAT3 inhibited the CML cells from developing drug-persistence, inhibition of STAT3 using a small molecule inhibitor sensitized the persistent CML cells to TKI treatment. Interestingly, given the role of phosphorylated STAT3 as a transcription factor, it localized uniquely to genes regulating metabolic pathways in the TKI-persistent CML stem and progenitor cells. Subsequently, we observed that STAT3 dysregulated mitochondrial metabolism forcing the TKI-persistent CML cells to depend on glycolysis, unlike TKI-sensitive CML cells, which are more reliant on oxidative phosphorylation. Finally, targeting pyruvate kinase M2, a rate-limiting glycolytic enzyme, specifically eradicated the TKI-persistent CML cells. By exploring the role of STAT3 in altering metabolism, we provide critical insight into identifying potential therapeutic targets for eliminating TKI-persistent LSCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Szklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1131 · Cited by 17,749
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
Tumour heterogeneity and resistance to cancer therapies
Dagogo-Jack, I., & Shaw, A. T. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.166 · Cited by 3,846
deepTools: a flexible platform for exploring deep-sequencing data
Ramírez, F., Dündar, F., Diehl, S., Grüning, B. A., & Manke, T. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku365 · Cited by 3,738
MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis
Chong, J., Soufan, O., Li, C., Caraus, I., Li, S., Bourque, G., Wishart, D. S., & Xia, J. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky310 · Cited by 3,629
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791
The molecular biology of chronic myeloid leukemia
Deininger, M. W. N., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.10.3343 · Cited by 1,667
Mahon, F.-X., Réa, D., Guilhot, J., Guilhot, F., Huguet, F., Nicolini, F., Legros, L., Charbonnier, A., Guerci, A., Varet, B., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70233-3 · Cited by 1,550
Lagadinou, E. D., Sach, A., Callahan, K., Rossi, R. M., Neering, S. J., Minhajuddin, M., Ashton, J. M., Pei, S., Grose, V., O’Dwyer, K. M., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.013 · Cited by 1,399
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
Hochhaus, A., Larson, R. A., Guilhot, F., Radich, J. P., Branford, S., Hughes, T. P., Baccarani, M., Deininger, M. W., Cervantes, F., Fujihara, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609324 · Cited by 1,285
A clustering approach for identification of enriched domains from histone modification ChIP-Seq data
Zang, C., Schones, D. E., Zeng, C., Cui, K., Zhao, K., & Peng, W. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp340 · Cited by 1,057
Function of Mitochondrial Stat3 in Cellular Respiration
Wegrzyn, J., Potla, R., Chwae, Y.-J., Sepuri, N. B. V., Zhang, Q., Koeck, T., Derecka, M., Szczepanek, K., Szelag, M., Gornicka, A., et al. (2009) · Science · doi:10.1126/science.1164551 · Cited by 1,014
Shen, L., Shao, N., Liu, X., & Nestler, E. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-284 · Cited by 887
Fialkow, P. J., Jacobson, R. J., & Papayannopoulou, T. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90124-3 · Cited by 857
Wang, T., Fahrmann, J. F., Lee, H., Li, Y.-J., Tripathi, S. C., Yue, C., Zhang, C., Lifshitz, V., Song, J., Yuan, Y., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.001 · Cited by 825
Takubo, K., Nagamatsu, G., Kobayashi, C. I., Nakamura-Ishizu, A., Kobayashi, H., Ikeda, E., Goda, N., Rahimi, Y., Johnson, R. S., Soga, T., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.10.011 · Cited by 806
Toward Minimal Residual Disease-Directed Therapy in Melanoma
Rambow, F., Rogiers, A., Marin-Bejar, O., Aibar, S., Femel, J., Dewaele, M., Karras, P., Brown, D., Chang, Y. H., Debiec-Rychter, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.06.025 · Cited by 771
Corbin, A. S., Agarwal, A., Loriaux, M., Cortes, J., Deininger, M. W., & Druker, B. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci35721 · Cited by 765
Samudio, I., Harmancey, R., Fiegl, M., Kantarjian, H., Konopleva, M., Korchin, B., Kaluarachchi, K., Bornmann, W., Duvvuri, S., Taegtmeyer, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38942 · Cited by 709
A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
Bai, L., Zhou, H., Xu, R., Zhao, Y., Chinnaswamy, K., McEachern, D., Chen, J., Yang, C.-Y., Liu, Z., Wang, M., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.10.002 · Cited by 652
Self-citationAnalysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells
Foudi, A., Hochedlinger, K., Van Buren, D., Schindler, J. W., Jaenisch, R., Carey, V., & Hock, H. (2009) · Nature Biotechnology · doi:10.1038/nbt.1517 · Cited by 586
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
Jones, C. L., Stevens, B. M., D'Alessandro, A., Reisz, J. A., Culp-Hill, R., Nemkov, T., Pei, S., Khan, N., Adane, B., Ye, H., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.10.005 · Cited by 585
Self-citationKuntz, E. M., Baquero, P., Michie, A. M., Dunn, K., Tardito, S., Holyoake, T. L., Helgason, G. V., & Gottlieb, E. (2017) · Nature Medicine · doi:10.1038/nm.4399 · Cited by 546
Pucino, V., Certo, M., Bulusu, V., Cucchi, D., Goldmann, K., Pontarini, E., Haas, R., Smith, J., Headland, S. E., Blighe, K., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.10.004 · Cited by 530
Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival
Hamilton, A., Helgason, G. V., Schemionek, M., Zhang, B., Myssina, S., Allan, E. K., Nicolini, F. E., Müller-Tidow, C., Bhatia, R., Brunton, V. G., et al. (2012) · Blood · doi:10.1182/blood-2010-12-326843 · Cited by 435
Self-citationIwamaru, A., Szymanski, S., Iwado, E., Aoki, H., Yokoyama, T., Fokt, I., Hess, K., Conrad, C., Madden, T., Sawaya, R., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210031 · Cited by 370
Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells
Fendt, S.-M., Bell, E. L., Keibler, M. A., Olenchock, B. A., Mayers, J. R., Wasylenko, T. M., Vokes, N. I., Guarente, L., Heiden, M. G. V., & Stephanopoulos, G. (2013) · Nature Communications · doi:10.1038/ncomms3236 · Cited by 364
Cell-State-Specific Metabolic Dependency in Hematopoiesis and Leukemogenesis
Wang, Y.-H., Israelsen, W. J., Lee, D., Yu, V. W. C., Jeanson, N. T., Clish, C. B., Cantley, L. C., Vander Heiden, M. G., & Scadden, D. T. (2014) · Cell · doi:10.1016/j.cell.2014.07.048 · Cited by 348
The chronic myeloid leukemia stem cell: stemming the tide of persistence
Holyoake, T. L., & Vetrie, D. (2017) · Blood · doi:10.1182/blood-2016-09-696013 · Cited by 314
Improved peak-calling with MACS2
Gaspar, J. M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/496521 · Cited by 301
Yamashita, K., Motohashi, M., & Yashiki, T. (1989) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)83043-1 · Cited by 285
AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species
Juntilla, M. M., Patil, V. D., Calamito, M., Joshi, R. P., Birnbaum, M. J., & Koretzky, G. A. (2010) · Blood · doi:10.1182/blood-2009-09-241000 · Cited by 284
Zhang, B., Strauss, A. C., Chu, S., Li, M., Ho, Y., Shiang, K.-D., Snyder, D. S., Huettner, C. S., Shultz, L., Holyoake, T., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.011 · Cited by 256
Self-citationImatinib (STI571)-Mediated Changes in Glucose Metabolism in Human Leukemia BCR-ABL-Positive Cells
Gottschalk, S., Anderson, N., Hainz, C., Eckhardt, S. G., & Serkova, N. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0039 · Cited by 256
Nemkov, T., Hansen, K. C., & D'Alessandro, A. (2017) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.7834 · Cited by 256
Self-citationA STAT3-mediated metabolic switch is involved in tumour transformation and STAT3 addiction
Demaria, M., Giorgi, C., Lebiedzinska, M., Esposito, G., D'Angeli, L., Bartoli, A., Gough, D. J., Turkson, J., Levy, D. E., Watson, C. J., et al. (2010) · Aging · doi:10.18632/aging.100232 · Cited by 250
Xu, S., Grullon, S., Ge, K., & Peng, W. (2014) · Methods in Molecular Biology · doi:10.1007/978-1-4939-0512-6_5 · Cited by 248
Wingelhofer, B., Neubauer, H. A., Valent, P., Han, X., Constantinescu, S. N., Gunning, P. T., Müller, M., & Moriggl, R. (2018) · Leukemia · doi:10.1038/s41375-018-0117-x · Cited by 243
Stat5 is indispensable for the maintenance of bcr/abl ‐positive leukaemia
Hoelbl, A., Schuster, C., Kovacic, B., Zhu, B., Wickre, M., Hoelzl, M. A., Fajmann, S., Grebien, F., Warsch, W., Stengl, G., et al. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000062 · Cited by 239
Heidel, F. H., Bullinger, L., Feng, Z., Wang, Z., Neff, T. A., Stein, L., Kalaitzidis, D., Lane, S. W., & Armstrong, S. A. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.02.017 · Cited by 225
Do STAT3 inhibitors have potential in the future for cancer therapy?
Wong, A. L. A., Hirpara, J. L., Pervaiz, S., Eu, J.-Q., Sethi, G., & Goh, B.-C. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1351941 · Cited by 225
Szczepanek, K., Chen, Q., Derecka, M., Salloum, F. N., Zhang, Q., Szelag, M., Cichy, J., Kukreja, R. C., Dulak, J., Lesnefsky, E. J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.226209 · Cited by 224
Infertility treated with donor specific lymphocytes in recurrent idiopathic spontaneous abortion.
Bernstein, I. L., Bernstein, D. I., Balakrishnan, K., & Korbee, L. L. (1989) · PubMed · Cited by 221
Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation
Hoelbl, A., Kovacic, B., Kerenyi, M. A., Simma, O., Warsch, W., Cui, Y., Beug, H., Hennighausen, L., Moriggl, R., & Sexl, V. (2006) · Blood · doi:10.1182/blood-2005-09-3596 · Cited by 218
Phanstiel, D. H., Boyle, A. P., Araya, C. L., & Snyder, M. P. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu379 · Cited by 194
Lin, L., Hutzen, B., Li, P.-K., Ball, S., Zuo, M., DeAngelis, S., Foust, E., Sobo, M., Friedman, L., Bhasin, D., et al. (2010) · Neoplasia · doi:10.1593/neo.91196 · Cited by 192
Koschmieder, S., Göttgens, B., Zhang, P., Iwasaki-Arai, J., Akashi, K., Kutok, J. L., Dayaram, T., Geary, K., Green, A. R., Tenen, D. G., et al. (2005) · Blood · doi:10.1182/blood-2003-12-4369 · Cited by 188
Self-citationCarbognin, E., Betto, R. M., Soriano, M. E., Smith, A. G., & Martello, G. (2016) · The EMBO Journal · doi:10.15252/embj.201592629 · Cited by 188
Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes
Matre, P., Velez, J., Jacamo, R., Qi, Y., Su, X., Cai, T., Chan, S. M., Lodi, A., Sweeney, S. R., Ma, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12944 · Cited by 185
Boren, J., Cascante, M., Marin, S., Comı́n-Anduix, B., Centelles, J. J., Lim, S., Bassilian, S., Ahmed, S., Lee, W.-N. P., & Boros, L. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105796200 · Cited by 182
Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis
Zhao, X., Zhu, Y., Hu, J., Jiang, L., Li, L., Jia, S., & Zen, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-31615-y · Cited by 151
Bewry, N. N., Nair, R. R., Emmons, M. F., Boulware, D., Pinilla-Ibarz, J., & Hazlehurst, L. A. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0314 · Cited by 150
When fats commit crimes: fatty acid metabolism, cancer stemness and therapeutic resistance
Kuo, C., & Ann, D. K. (2018) · Cancer Communications · doi:10.1186/s40880-018-0317-9 · Cited by 146
Poli, V., & Camporeale, A. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00121 · Cited by 137
Divakaruni, A. S., Rogers, G. W., & Murphy, A. N. (2014) · Current Protocols in Toxicology · doi:10.1002/0471140856.tx2502s60 · Cited by 136
Eiring, A. M., Page, B. D. G., Kraft, I. L., Mason, C. C., Vellore, N. A., Resetca, D., Zabriskie, M. S., Zhang, T. Y., Khorashad, J. S., Engar, A. J., et al. (2015) · Leukemia · doi:10.1038/leu.2014.245 · Cited by 131
STAT3 Undergoes Acetylation-dependent Mitochondrial Translocation to Regulate Pyruvate Metabolism
Xu, Y. S., Liang, J. J., Wang, Y., Zhao, X.-Z. J., Xu, L., Xu, Y.-Y., Zou, Q. C., Zhang, J. M., Tu, C.-E., Cui, Y.-G., et al. (2016) · Scientific Reports · doi:10.1038/srep39517 · Cited by 131
Welner, R. S., Amabile, G., Bararia, D., Czibere, A., Yang, H., Zhang, H., Pontes, L. L. D. F., Ye, M., Levantini, E., Di Ruscio, A., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.04.004 · Cited by 129
Self-citationNovel activators and small-molecule inhibitors of STAT3 in cancer
Yang, L., Lin, S., Xu, L., Lin, J., Zhao, C., & Huang, X. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.10.005 · Cited by 128
Abnormalities in Glucose Uptake and Metabolism in Imatinib-Resistant Human BCR-ABL–Positive Cells
Kominsky, D. J., Klawitter, J., Brown, J. L., Boros, L. G., Melo, J. V., Eckhardt, S. G., & Serkova, N. J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3291 · Cited by 119
Ning, X., Qi, H., Li, R., Li, Y., Jin, Y., McNutt, M. A., Liu, J., & Yin, Y. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.064 · Cited by 119
Meier, J. A., Hyun, M., Cantwell, M. T., Raza, A., Mertens, C., Raje, V., Sisler, J. D., Tracy, E., Torres-Odio, S., Gispert, S., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aag2588 · Cited by 118
Li, Q., Zhang, D., Chen, X., He, L., Li, T., Xu, X., & Li, M. (2015) · Scientific Reports · doi:10.1038/srep16082 · Cited by 114
Caza, M., & Kronstad, J. W. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00212 · Cited by 107
アミノ酸代謝の阻害はヒト白血病幹細胞を選択的に標的とする【JST・京大機械翻訳】
Courtney, L., Brett, M. S., Angelo, D., Julie, A. R., Culp‐Hill, R., Travis, N., Pei, S., Khan, N., Adane, B., Ye, H., et al. (2018) · Cancer Cell · Cited by 96
SIRT1 regulates metabolism and leukemogenic potential in CML stem cells
Abraham, A., Qiu, S., Chacko, B. K., Li, H., Paterson, A., He, J., Agarwal, P., Shah, M., Welner, R., Darley-Usmar, V. M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127080 · Cited by 90
Self-citationLonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro
Jørgensen, H. G., Allan, E. K., Graham, S. M., Godden, J., Richmond, L., Elliott, M. A., Mountford, J. C., Eaves, C. J., & Holyoake, T. L. (2005) · Leukemia · doi:10.1038/sj.leu.2403785 · Cited by 70
PKM2 promotes reductive glutamine metabolism
Miao, L., Yuanyuan, W., Yuxia, R., Changsen, B., Li, Q., Yanfen, C., Guoguang, Y., & Binghui, L. (2018) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2018.0122 · Cited by 55
Acetylation of C/EBPα inhibits its granulopoietic function
Bararia, D., Kwok, H. S., Welner, R. S., Numata, A., Sárosi, M. B., Yang, H., Wee, S., Tschuri, S., Ray, D., Weigert, O., et al. (2016) · Nature Communications · doi:10.1038/ncomms10968 · Cited by 49
Self-citationNie, Z.-Y., Yang, L., Liu, X., Yang, Z., Yang, G., Zhou, J., Qin, Y., Yu, J., Jiang, L., Wen, J., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0051 · Cited by 43
Cui, P., Wei, F., Hou, J., Su, Y., Wang, J., & Wang, S. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109598 · Cited by 31
Cited by
Mitochondrial STAT3 exacerbates LPS-induced sepsis by driving CPT1a-mediated fatty acid oxidation
Li, R., Li, X., Zhao, J., Meng, F., Yao, C., Bao, E., Sun, N., Chen, X., Cheng, W., Hua, H., et al. (2022) · Theranostics · doi:10.7150/thno.63751 · Cited by 158
Metabolomics in drug research and development: The recent advances in technologies and applications
Pang, H., & Hu, Z. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.05.021 · Cited by 97
Deregulated transcription factors in cancer cell metabolisms and reprogramming
Kant, R., Manne, R., Anas, M., Penugurti, V., Chen, T., Pan, B., Hsu, C.-C., & Lin, H. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.001 · Cited by 81
Deregulated transcription factors in the emerging cancer hallmarks
Hasan, A., Khan, N. A., Shahab Uddin, M. S., Khan, A. Q., & Steinhoff, M. S. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.12.001 · Cited by 48
Metabolic adaptation to tyrosine kinase inhibition in leukemia stem cells
Qiu, S., Sheth, V., Yan, C., Liu, J., Chacko, B. K., Li, H., Crossman, D. K., Fortmann, S. D., Aryal, S., Rennhack, A., et al. (2023) · Blood · doi:10.1182/blood.2022018196 · Cited by 45
Self-citation
Metadata
- Authors
- Patel, S. B., Nemkov, T., Stefanoni, D., Benavides, G. A., Bassal, M. A., Crown, B. L., Matkins, V. R., Camacho, V., Kuznetsova, V., Hoang, A. T., Tenen, D. E., Wolock, S. L., Park, J., Ying, L., Yue, Z., Chen, J. Y., Yang, H., Tenen, D. G., Ferrell, P. B., Lu, R., Darley-Usmar, V., D’Alessandro, A., Bhatia, R., & Welner, R. S.
- Affiliations
- University of Alabama at Birmingham (US)
- University of Colorado Anschutz (US)
- Harvard University (US)
- Beth Israel Deaconess Medical Center (US)
- Dicerna Pharmaceuticals (United States) (US)
- National University of Singapore (SG)
- Vanderbilt University Medical Center (US)
- Corresponding author
- Welner, Robert S.
- ORCID
- Patel, Sweta B.
- Nemkov, Travis
- Stefanoni, Davide
- Benavides, Gloria A.
- Bassal, Mahmoud A.
- Crown, Brittany L.
- Camacho, Virginia
- Kuznetsova, Valeriya
- Wolock, Samuel L.
- Park, Jihye
- Yue, Zongliang
- Chen, Jake Y.
- Yang, Henry
- Tenen, Daniel G.
- Ferrell, Paul Brent
- Lu, Rui
- Darley-Usmar, Victor
- D’Alessandro, Angelo
- Bhatia, Ravi
- Welner, Robert S.
- Venue
- Leukemia
- Published
- 2021-06-12
- Volume
- 35
- Issue
- 12
- Pages
- 3371-3382
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- PMC
- PMC8632690
- OpenAlex
- W3171658473
- Cited by
- 56
- References
- 77
- Citations by year
- 2026: 11 · 2025: 10 · 2024: 13 · 2023: 11 · 2022: 8 · 2021: 3
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Leukemia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion, cc-by)
- Funders
- American Society of Hematology
- University of Alabama at Birmingham (P30-AI-027767, P30CA013148)
- University of Alabama (P30 CA013148, P30 AI027767)
- National Institutes of Health (P30-AI- 027767, P30-CA- 013148, CA013148, AI027767)
- Center for AIDS Research, University of Washington (CA013148, P30 AI027767, AI027767)
- National Heart, Lung, and Blood Institute (K23HL138291, P01HL131477)
- National Cancer Institute (R01CA095684, CA013148, R35CA197697, R01CA248794, P30CA013148)
- National Institute of Allergy and Infectious Diseases (P30AI027767)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- STAT3, chronic myeloid leukemia, drug resistance, leukemia stem cells, tyrosine kinase inhibitors, mitochondrial metabolism, glycolysis, oxidative phosphorylation, PKM2, metabolic reprogramming, STAT3 inhibitor, relapse
- MeSH terms
- Animals, Female, Glycolysis, Male, Neoplastic Stem Cells, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Apoptosis, Drug Resistance, Neoplasm, Protein Kinase Inhibitors, STAT3 Transcription Factor, Mice, Small Molecule Libraries, Metabolome, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.